Ellen Miller
Pulmonary Disease · Lincoln, NENPI 1932178555
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 96 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $721 and has fallen 56.3% since, to $316 in 2022. That places this record below the midpoint for pulmonary disease clinicians in NE, where the typical reported total is $2,614.
Across 96 payments — averaging $12.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$235
- GSK$199
- Jazz Pharmaceuticals Inc.$109
- Grifols USA, LLC$87
- Regeneron Healthcare Solutions, Inc.$74
- Boehringer Ingelheim$56
- plus $485 from 17 others
What the payments were for
- Food & beverage$1,22899%
- Education$161%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 15 | $235 |
| GSK | 28 | $199 |
| Jazz Pharmaceuticals Inc. | 7 | $109 |
| Grifols USA, LLC | 5 | $87 |
| Regeneron Healthcare Solutions, Inc. | 5 | $74 |
| Boehringer Ingelheim | 4 | $56 |
| Sanofi | 3 | $54 |
| Harmony Biosciences LLC | 3 | $53 |
| Amgen | 3 | $53 |
| Mylan Specialty L.p. | 3 | $46 |
| Philips North America LLC | 3 | $42 |
| Electromed, Inc. | 2 | $32 |
| Johnson & Johnson | 2 | $31 |
| AbbVie | 2 | $29 |
| Novartis | 2 | $27 |
| Circassia Inc. | 2 | $24 |
| Insmed, Inc. | 1 | $16 |
| Pfizer | 1 | $14 |
| Axsome Therapeutics, Inc. | 1 | $14 |
| Merck | 1 | $13 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $13 |
| Genentech USA, Inc. | 1 | $12 |
| Shire North American Group Inc | 1 | $12 |
How this compares
$1,244 in reported general payments places this provider in the 35th percentile of 81 pulmonary disease providers in Nebraska.
Other pulmonary disease in Lincoln
- Ryan MartinLincoln$600K
- Douglas FiedlerLincoln$23K
- Kevin ReichmuthLincoln$22K
- Harvey HopkinsLincoln$18K
- William JohnsonLincoln$18K
- Matthew MaslonkaLincoln$14K
- Jakeb RiggleLincoln$13K
- Jonathan SpencerLincoln$9K
- Louis VioliLincoln$6K
- Jeffrey JarrettLincoln$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.